Significant reductions in HBeAg from baseline were achieved in all treatment groups @ weeks posttreatment ; reductions were comparable across treatment arms ( shown as log@ Paul Ehrlich international units -LSB- PEIU -RSB- / mL ) : monotherapy : -@ ( SD , @ ) ; ETV add-on : -@ ( SD , @ ) ; ETV pretreatment : -@ ( SD , @ ) .